Learn more

LICHTER JAY

Overview
  • Total Patents
    23
About

LICHTER JAY has a total of 23 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ASTELLAS DEUTSCHLAND GMBH, NANJING ZEHENG PHARMACEUTICAL SCIENCE & TECH CO LTD and CHASE PHARMACEUTICALS CORP.

Patent filings in countries

World map showing LICHTER JAYs patent filings in countries

Patent filings per year

Chart showing LICHTER JAYs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lichter Jay 23
#2 Trammel Andrew M 14
#3 Lebel Carl 14
#4 Piu Fabrice 14
#5 Dellamary Luis A 13
#6 Ye Qiang 13
#7 Harris Jeffrey P 13
#8 Vollrath Benedikt 12
#9 Duron Sergio G 11
#10 Scaife Michael Christopher 8

Latest patents

Publication Filing date Title
US2013225575A1 Methods for treating neurological conditions
WO2011049954A2 Compositions comprising wnt modulators or neurotoxins for the treatment of otic disorders
US2012270844A1 Methods for treating alzheimer's disease
US2012184547A1 Methods for treating schizophrenia
US2010022661A1 Controlled release compositions for modulating free-radical induced damage and methods of use thereof
US2010015228A1 Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
US2010036000A1 Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US2010015263A1 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
US2010004225A1 Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
US2009297533A1 Controlled release immunomodulator compositions and methods for the treatment of otic disorders
WO2007008821A2 Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (rbp), and/or serum retinol-rbp modulation